$IMLFF InMed Pharmaceuticals has taken a unique lo
Post# of 7841
(Total Views: 105)
Posted On: 02/16/2017 9:46:22 AM
$IMLFF InMed Pharmaceuticals has taken a unique low-cost / high-yield approach to developing cannabinoid-based compounds for inclusion in their products. By utilizing the process currently employed to manufacture insulin for diabetes, the company's strategy can scalably produce a wide range of cannabinoids beyond simply THC and CBD. These cannabinoids could have broad-reaching potential, but haven't been studied extensively because they are difficult to extract from the cannabis plant at scale.
https://finance.yahoo.com/news/inmed-pharma-c...00706.html
https://finance.yahoo.com/news/inmed-pharma-c...00706.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼